Clarify Health is an outcomes company. We work with health systems on the problem most analytics vendors avoid: finding where the care that is best for patients and the care that sustains the health system have come apart, then closing that gap.
Clarify Meridian™ and Clarify Arrival™ are built on the same intelligence layer, drawing on 300 million patient journeys and 5.6 trillion price transparency rates. Meridian sees the opportunity across the network: referral leakage, market share gaps, contract economics, site of service decisions and value-based performance. Arrival acts on it, guiding patients to the care they need and measuring every path on one outcome, a booked in-network appointment. Our forward-deployed teams embed alongside the liaisons, contracting leads and service line leaders who do the work, and our economics are tied to measurable results.
DermTech 2.0 provides genomic analysis of skin samples collected non-invasively using its proprietary Smart Sticker platform technology. DermTech 2.0 develops and markets products to facilitate the assessment of melanoma, including the DermTech Melanoma Test, and offers DermTech Stratum, a precision biomarker service offering for biopharmaceutical and research partners.
Did you know that 1 in 5 people can develop skin cancer during their lifetime? While being one of the most prevalent types of cancer, if caught in time, skin cancer has the highest success rate in treatment and recovery. The timely reaction makes regular and reliable self-skin exams essential.
With over 3 million users worldwide, SkinVision provides a medical service that democratizes access to reliable, convenient and accurate detection of risk of the most common types of skin cancer, helping to bring the right people in front of the healthcare practitioner in time for successful treatment. Empowered by a highly accurate AI-based algorithm, our app combines cutting-edge technology with best-in-class dermatologists expertise and support. SkinVision is clinically validated and can detect signs of most common skin cancers with 95% sensitivity.
At SkinVision, we are continuously expanding our ecosystem. Together we are focused on taking skin health care to the next level, creating the highest patient-doctor value and eradicating skin cancer mortality worldwide. We are on a mission of saving the lives of 250.000 people in the next decades.
If you share our vision and would like to become a SkinVision partner, write to us at partners@skinvision.com.
Want to join us on this incredible journey and be a part of our dynamic team, check out our careers page https://skinvision1.recruitee.com/